80 related articles for article (PubMed ID: 10716336)
1. A novel EBNA-1 tag system for high level expression and efficient detection of fusion proteins in vitro and in vivo.
Chen MR; Huang H; Fen CY; Chen JY
J Virol Methods; 2000 Mar; 85(1-2):35-41. PubMed ID: 10716336
[TBL] [Abstract][Full Text] [Related]
2. Conserved regions in the Epstein-Barr virus leader protein define distinct domains required for nuclear localization and transcriptional cooperation with EBNA2.
Peng R; Tan J; Ling PD
J Virol; 2000 Nov; 74(21):9953-63. PubMed ID: 11024123
[TBL] [Abstract][Full Text] [Related]
3. P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus.
Wang Y; Finan JE; Middeldorp JM; Hayward SD
Virology; 1997 Sep; 236(1):18-29. PubMed ID: 9299613
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells.
Rasul AE; Nagy N; Sohlberg E; Ádori M; Claesson HE; Klein G; Klein E
J Immunol Methods; 2012 Nov; 385(1-2):60-70. PubMed ID: 22921685
[TBL] [Abstract][Full Text] [Related]
5. Epstein-barr virus nuclear antigen-1 binds to nuclear transporter karyopherin alpha1/NPI-1 in addition to karyopherin alpha2/Rch1.
Ito S; Ikeda M; Kato N; Matsumoto A; Ishikawa Y; Kumakubo S; Yanagi K
Virology; 2000 Jan; 266(1):110-9. PubMed ID: 10612665
[TBL] [Abstract][Full Text] [Related]
6. A protein kinase activity associated with Epstein-Barr virus BGLF4 phosphorylates the viral early antigen EA-D in vitro.
Chen MR; Chang SJ; Huang H; Chen JY
J Virol; 2000 Apr; 74(7):3093-104. PubMed ID: 10708424
[TBL] [Abstract][Full Text] [Related]
7. Precipitation of the Epstein-Barr virus protein EBNA 2 by an EBNA 3c-specific monoclonal antibody.
Maunders MJ; Petti L; Rowe M
J Gen Virol; 1994 Apr; 75 ( Pt 4)():769-78. PubMed ID: 7512118
[TBL] [Abstract][Full Text] [Related]
8. Biochemical characterization of Epstein-Barr virus nuclear antigen 3A and 3C proteins.
Sample C; Parker B
Virology; 1994 Dec; 205(2):534-9. PubMed ID: 7975254
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Epstein-Barr virus BGLF4 kinase expression control at the transcriptional and translational levels.
Wang JT; Chuang YC; Chen KL; Lu CC; Doong SL; Cheng HH; Chen YL; Liu TY; Chang Y; Han CH; Yeh SW; Chen MR
J Gen Virol; 2010 Sep; 91(Pt 9):2186-96. PubMed ID: 20444992
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus nuclear protein 2 has at least two N-terminal domains that mediate self-association.
Harada S; Yalamanchili R; Kieff E
J Virol; 2001 Mar; 75(5):2482-7. PubMed ID: 11160754
[TBL] [Abstract][Full Text] [Related]
11. Interaction of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP) with HS1-associated protein X-1: implication of cytoplasmic function of EBNA-LP.
Kawaguchi Y; Nakajima K; Igarashi M; Morita T; Tanaka M; Suzuki M; Yokoyama A; Matsuda G; Kato K; Kanamori M; Hirai K
J Virol; 2000 Nov; 74(21):10104-11. PubMed ID: 11024139
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2.
Lin J; Johannsen E; Robertson E; Kieff E
J Virol; 2002 Jan; 76(1):232-42. PubMed ID: 11739688
[TBL] [Abstract][Full Text] [Related]
13. Direct and indirect regulation of cytokine and cell cycle proteins by EBNA-2 during Epstein-Barr virus infection.
Spender LC; Cornish GH; Rowland B; Kempkes B; Farrell PJ
J Virol; 2001 Apr; 75(8):3537-46. PubMed ID: 11264343
[TBL] [Abstract][Full Text] [Related]
14. Development of a monoclonal antibody against Epstein-Barr virus nuclear antigen leader protein (EBNA-LP) that can detect EBNA-LP expressed in P3HR1 cells.
Shaku F; Matsuda G; Furuya R; Kamagata C; Igarashi M; Tanaka M; Kanamori M; Nishiyama Y; Yamamoto N; Kawaguchi Y
Microbiol Immunol; 2005; 49(5):477-83. PubMed ID: 15905610
[TBL] [Abstract][Full Text] [Related]
15. The Epstein-Barr virus nuclear antigen-6 protein co-localizes with EBNA-3 and survival of motor neurons protein.
Krauer KG; Buck M; Belzer DK; Flanagan J; Chojnowski GM; Sculley TB
Virology; 2004 Jan; 318(1):280-94. PubMed ID: 14972554
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) forms complexes with a cellular anti-apoptosis protein Bcl-2 or its EBV counterpart BHRF1 through HS1-associated protein X-1.
Matsuda G; Nakajima K; Kawaguchi Y; Yamanashi Y; Hirai K
Microbiol Immunol; 2003; 47(1):91-9. PubMed ID: 12636258
[TBL] [Abstract][Full Text] [Related]
17. Cell specific internal translation efficiency of Epstein-Barr virus present in solid organ transplant patients.
Isaksson A; Berggren M; Ekeland-Sjöberg K; Samuelsson T; Ricksten A
J Med Virol; 2007 May; 79(5):573-81. PubMed ID: 17385682
[TBL] [Abstract][Full Text] [Related]
18. Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses.
Murray RJ; Kurilla MG; Griffin HM; Brooks JM; Mackett M; Arrand JR; Rowe M; Burrows SR; Moss DJ; Kieff E
Proc Natl Acad Sci U S A; 1990 Apr; 87(8):2906-10. PubMed ID: 2158098
[TBL] [Abstract][Full Text] [Related]
19. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
Van Scoy S; Watakabe I; Krainer AR; Hearing J
Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
[TBL] [Abstract][Full Text] [Related]
20. Physical association between the EBV protein EBNA-1 and P32/TAP/hyaluronectin.
Chen MR; Yang JF; Wu CW; Middeldorp JM; Chen JY
J Biomed Sci; 1998; 5(3):173-9. PubMed ID: 9678487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
